​

Evoke Pharma (EVOK) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

EVOK Stock Forecast

Evoke Pharma (EVOK) stock forecast, based on 1 Wall Street analysts, predicts a 12-month average price target of $18.00, with a high of $18.00 and a low of $18.00. This represents a 299.11% increase from the last price of $4.51.

- $4 $8 $12 $16 $20 High: $18 Avg: $18 Low: $18 Last Closed Price: $4.51

EVOK Stock Rating

Evoke Pharma stock's rating consensus is Buy, based on 1 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 1 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 1 0 1 Strong Sell Sell Hold Buy Strong Buy

EVOK Forecast vs Benchmarks

TypeNameUpside
StockEvoke Pharma299.11%
SectorHealthcare Stocks 25.20%
IndustrySpecialty & Generic Drug Manufacturers Stocks24.78%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$18.00
Last Closing Price$4.51$4.51$4.51
Upside/Downside--299.11%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 251----1
Dec, 241----1
Nov, 2415---6
Oct, 2415---6
Sep, 2415---6
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 28, 2024Yale JenLaidlaw$18.00$7.08154.24%299.11%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Oct 28, 2024LaidlawBuyBuyhold

Financial Forecast

EPS Forecast

$-80 $-63 $-46 $-29 $-12 $5 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-6.24$-3.37$-2.60$-2.33---
Avg Forecast$-77.04$-43.20$-30.96$-26.76$-3.98$0.48$2.59
High Forecast$-77.04$-43.20$-30.96$-26.76$-3.98$0.48$2.59
Low Forecast$-77.04$-43.20$-30.96$-26.76$-3.98$0.48$2.59
Surprise %-91.90%-92.20%-91.60%-91.29%---

Revenue Forecast

$0 $7M $14M $21M $28M $35M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$23.02K$1.62M$2.51M$5.18M---
Avg Forecast$845.00K$1.76M$2.60M$5.14M$10.02M$20.00M$32.03M
High Forecast$845.00K$1.76M$2.60M$5.14M$10.02M$20.00M$32.03M
Low Forecast$845.00K$1.76M$2.60M$5.14M$10.02M$20.00M$32.03M
Surprise %-97.28%-8.32%-3.55%0.85%---

Net Income Forecast

$-300M $-230M $-160M $-90M $-20M $50M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-13.26M$-9.03M$-8.16M$-7.79M---
Avg Forecast$-257.55M$-144.42M$-8.63M$-7.46M$-1.11M$133.72K$721.55K
High Forecast$-257.55M$-144.42M$-8.63M$-7.46M$-1.11M$133.72K$721.55K
Low Forecast$-257.55M$-144.42M$-8.63M$-7.46M$-1.11M$133.72K$721.55K
Surprise %-94.85%-93.75%-5.37%4.52%---

EVOK Forecast FAQ

Is Evoke Pharma stock a buy?

Evoke Pharma stock has a consensus rating of Buy, based on 1 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 1 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Evoke Pharma is a favorable investment for most analysts.

What is Evoke Pharma's price target?

Evoke Pharma's price target, set by 1 Wall Street analysts, averages $18 over the next 12 months. The price target range spans from $18 at the low end to $18 at the high end, suggesting a potential 299.11% change from the previous close price of $4.51.

How does Evoke Pharma stock forecast compare to the average forecast of its sector, industry, and investment themes?

Evoke Pharma stock forecast shows a 299.11% upside, outperforming the average forecast for the healthcare stocks sector (25.20%) and outperforming the specialty & generic drug manufacturers stocks industry (24.78%).

What is the breakdown of analyst ratings for Evoke Pharma over the past three months?

  • January 2025: 100.00% Strong Buy, 0% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 100.00% Strong Buy, 0% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • November 2024: 16.67% Strong Buy, 83.33% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Evoke Pharma’s EPS forecast?

Evoke Pharma's average annual EPS forecast for its fiscal year ending in December is -3.98 for 2024, a 70.82% increase from the reported $-2.33 in 2023. The prediction for 2025 is $0.48, and $2.59 for 2026.

What is Evoke Pharma’s revenue forecast?

Evoke Pharma's average annual revenue forecast for its fiscal year ending in December is $10.02M for 2024, a 93.49% increase from the reported $5.18M in 2023. The forecast for 2025 is $20M, and $32.03M for 2026.

What is Evoke Pharma’s net income forecast?

For its fiscal year ending in December, Evoke Pharma's average annual net income forecast is $-1.109M for 2024, reflecting a -85.77% decrease from the reported $-7.792M in 2023. The projection for 2025 is $133.72K, and $721.55K for 2026.